May 24, 2017
Tissue-indepedent cancer drug gets fast-track approval from US regulator
news@nature.com - Fetched: May 24th, 2017, 6:00pm UTC
Treatment will be given to patients based on a tumour’s molecular markers, rather than its location in the body.
Nature News doi: 10.1038/nature.2017.22054